Good Laboratory Standards for Clinical Next-Generation Sequencing Cancer Panel Tests.

High prevalence of TP53 mutations is associated with poor survival and an EMT signature in gliosarcoma patients.

Simple Estimates of Symptomatic Intracranial Hemorrhage Risk and Outcome after Intravenous Thrombolysis Using Age and Stroke Severity.

The Value of Preoperative Positron Emission Tomography/Computed Tomography in Node-Negative Endometrial Cancer on Magnetic Resonance Imaging.

The immune checkpoint molecule V-set Ig domain-containing 4 is an independent prognostic factor for multiple myeloma.

Accuracy of Core Needle Biopsy Versus Fine Needle Aspiration Cytology for Diagnosing Salivary Gland Tumors.

Clinicopathological Significance of Minimal Extrathyroid Extension in Solitary Papillary Thyroid Carcinomas.

Defective pericyte recruitment of villous stromal vessels as the possible etiologic cause of hydropic change in complete hydatidiform mole.

Expression of carbonic anhydrase 9 is a novel prognostic marker in resectable hepatocellular carcinoma.

Immunoprofile-based subgrouping of urothelial bladder carcinomas for survival prediction.

Mixed carcinoid-mucinous adenocarcinoma arising in mature teratoma of mesentery.

Overexpression of C-reactive Protein as a Poor Prognostic Marker of Resectable Hepatocellular Carcinomas.

Peritoneal Carcinosarcoma and Ovarian Papillary Serous Carcinoma Are the Same Origin: Analysis of TP53
Mutation and Microsatellite Suggests a Monoclonal Origin.

A distinctive ovarian cancer molecular subgroup characterized by poor prognosis and somatic focal copy number amplifications at chromosome 19.

AZGP-1 immunohistochemical marker in prostate cancer: potential predictive marker of biochemical recurrence in post radical prostatectomy specimens.

Genomic Alterations in the RB Pathway Indicate Prognostic Outcomes of Early-Stage Lung Adenocarcinoma.

Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification.

The expression pattern of 19 genes predicts the histology of endometrial carcinoma.

Twist1 is a key regulator of cancer-associated fibroblasts.

Body mass index and outcome of ASC-H-interpreted cervical smears in postmenopausal women

Gliomatosis peritonei is associated with frequent recurrence, but does not affect overall survival in patients with ovarian immature teratoma.

Identification of differentially expressed genes according to chemosensitivity in advanced ovarian serous adenocarcinomas: expression of GRIA2 predicts better survival

Metastasis of Neuroendocrine Tumors Are Characterized by Increased Cell Proliferation and Reduced Expression of the ATM Gene

Somatic hypermutation and outcomes of platinum based chemotherapy in patients with high grade serous ovarian cancer.

Tumor size predicts survival in mucinous gastric carcinoma.